STAAR Surgical Company (STAA) reported fourth-quarter 2025 results with total revenue of $57.8 million, up 18.08% year-over-year, and gross profit of $43.7 million, up 38.21% year-over-year.
Despite the revenue gain, the company recorded an operating loss of -$22.8 million (down 18.17% year-over-year) and a net loss attributable to common shareholders of -$18.3 million (down 46.51% year-over-year). Diluted earnings per share were -$0.37 per share, a decline of 46.38% year-over-year.
Cost of sales declined to $14.1 million, down 18.74% year-over-year, helping expand gross margins even as the company remained unprofitable at the operating and net levels.
Analyst expectations called for revenue of $76.9 million and EPS of about $0.06; following the release, shares fell 4.86% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
STAAR Surgical Company Insider Trading Activity
STAAR Surgical Company insiders have traded $STAA stock on the open market 16 times in the past 6 months. Of those trades, 16 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $STAA stock by insiders over the last 6 months:
- PARTNERS, L.P. BROADWOOD has made 16 purchases buying 1,934,138 shares for an estimated $50,484,118 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
STAAR Surgical Company Hedge Fund Activity
We have seen 85 institutional investors add shares of STAAR Surgical Company stock to their portfolio, and 145 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 2,812,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $75,558,440
- RESONA ASSET MANAGEMENT CO.,LTD. removed 2,421,836 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $65,074,733
- BROADWOOD CAPITAL INC added 1,500,000 shares (+11.1%) to their portfolio in Q4 2025, for an estimated $34,635,000
- MAGNETAR FINANCIAL LLC added 1,268,019 shares (+105.3%) to their portfolio in Q4 2025, for an estimated $29,278,558
- GOLDMAN SACHS GROUP INC added 1,100,484 shares (+112.7%) to their portfolio in Q4 2025, for an estimated $25,410,175
- SAND GROVE CAPITAL MANAGEMENT LLP removed 829,123 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $19,144,450
- PALO ALTO INVESTORS LP removed 791,879 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $21,277,788
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
STAAR Surgical Company Analyst Ratings
Wall Street analysts have issued reports on $STAA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/28/2026
To track analyst ratings and price targets for STAAR Surgical Company, check out Quiver Quantitative's $STAA forecast page.
STAAR Surgical Company Price Targets
Multiple analysts have issued price targets for $STAA recently. We have seen 5 analysts offer price targets for $STAA in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Thomas Stephan from Stifel set a target price of $19.0 on 02/09/2026
- Michael Piccolo from Wedbush set a target price of $26.0 on 02/03/2026
- Young Li from Jefferies set a target price of $21.5 on 01/28/2026
- John Young from Canaccord Genuity set a target price of $22.0 on 01/16/2026
- Simran Kaur from Wells Fargo set a target price of $30.75 on 12/10/2025
